Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule

NCT01630668 is registered in ClinicalTrials.gov with Micropharma Limited as lead sponsor.

NCT NCT01630668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01630668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of a One-a-Day L. Reuteri NCIMB 30242 Probiotic Supplement Capsule
Lead sponsor
Micropharma Limited
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2012
Completion date
June 30, 2014
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia